Aura Biosciences Statistics
NASDAQ: AURAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.87-0.11 (-1.58%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Aura Biosciences by the numbers
Aura Biosciences has a market capitalization of $715.0 million based on 104.07M shares outstanding. With trailing EPS of $-1.59, Aura Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.2% above its 50-day average and 0.7% above its 200-day average.
Average daily trading volume is 847.22K shares, or about $5.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AURA valuation vs. peer median
| Metric | AURA | Peer median | Difference |
|---|---|---|---|
| Market cap | $714.99M | $759.09M | -6% |
| Avg. volume | 847.22K | 776.09K | +9% |
Peer median across 8 companies: GLUE, SLDB, ATTO, MGTX, PRME, BBTX, ODTX, IAM.
Valuation
- Market cap
- $714.99M
- EPS (TTM)
- $-1.59
- Shares outstanding
- 104.07M
Price and trading
- Previous close
- 6.98
- Open
- 6.51
- Day range
- 6.51 – 6.97
- 52-week range
- 4.73 – 9.54
- 52-week change
- +26.29%
- Beta
- —
- Volume
- 791.13K
- Average volume
- 847.22K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 714.99M
- Forward Pe
- -3.38
- Eps
- -1.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.54
- Week52 Low
- 4.73
- Avg Volume
- 847.22K
- Shares Outstanding
- 104.07M
- Ma50
- 6.53
- Ma200
- 6.82
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -27.95%
- Pct From52w Low
- 45.24%